Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Murrieta Genomics’ First Incubator Company Presenting at World Health Care Congress in Washington DC
  • USA - English


News provided by

Murrieta Genomics

Apr 30, 2018, 13:10 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

MURRIETA, Calif. (PRWEB) April 30, 2018 -- Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will see its first incubator company debut at one of the country’s largest and most respected healthcare conferences. EpigeneticsRX, a company dedicated to preventive medicine guided by epigenetic information, is being featured as a healthcare innovator at the World Health Care Congress 2018. The conference, featuring many of the world’s leaders in healthcare, is currently being held at the Marriott Wardman Park Hotel in Washington DC through May 2.

“Researchers need access to next generation sequencing technology in a collaborative environment where they can prove out their science while building a viable business model." - John Powers, Murrieta Genomics

Post this

“We are proud and honored to present EpigeneticsRX to the world at one of the more prestigious healthcare events in the country,” stated Mr. John Powers, a Founding Principal of Murrieta Genomics. “Deb Hubers has created an exciting new healthcare paradigm focused on promoting health and preventing disease by looking at how lifestyle choices, the environment and other factors affect a person’s genetic makeup. Using this information, doctors can now help their patients make decisions that can positively impact their health and possibly prevent future disease.”

“This has been a labor of love,” said Ms. Debra Hubers, founder and CEO of EpigeneticsRX. “Our mission is to empower and inspire providers and patients in optimizing genetic potential through precise, personalized protocols that positively impact patients’ health and future generations. Murrieta Genomics has been great to work with and has had a strong positive impact on our growth curve.”

EpigeneticsRX was chosen to participate in WHCC2018 as a healthcare innovator. Both Hubers and Powers will be attending the conference, demonstrating to attendees the power behind epigenetics and the impact this can make on future health. The 15th Annual World Health Care Congress convenes decision makers from payer, provider, pharmaceutical, government, and solutions organizations to inspire partnerships and defragment the current health care system, with over 1500 attendees, 350 speakers and 15 tracks.

Murrieta Genomics is currently in the process of building a state of the art next generation genomic sequencing facility in Murrieta, California. With proximity to three University of California research centers, the University of Southern California, the University of San Diego, and eight California State Universities, the incubator seeks to attract leading researchers in the genomics field who wish to bring discoveries to market.

A member of the Southern California Biomedical Council (SoCalBio), a trade association that serves biotech communities in the six counties that comprise the Greater Los Angeles region, the firm is actively networking with the companies, professionals and suppliers that can help genomic startups get off on the right foot. Murrieta Genomics enjoys strong relationships with local healthcare providers, small business development centers, SCORE, and economic development leaders in Riverside County.

“The understanding of genetics, DNA, gene expression and how they affect health are really just beginning to be understood,” continued Mr. Powers. “Researchers need access to next generation sequencing technology in a collaborative environment where they can prove out their science while building a viable business model. Murrieta Genomics offers the technology, science and business mentors that can help turn research into commercial enterprise.”

While healthcare is a focus of Murrieta Genomics, the company views the burgeoning field of genomics impacting agriculture as well, and sees applications of the technology in consumer products, forensics, and the veterinary field. “Genomics hold the key to so many dynamic new business models,” Powers added. “We have had conversations with entrepreneurs in all of these areas and believe that many of the companies that come out of our incubator will have a significant impact in a number of industries.”

About Murrieta Genomics, LLC
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The four founding principals of Murrieta Genomics have extensive background in business, finance, science and technology and they are supplemented with an advisory board and local mentors from both business and science. In addition to no-cost incubation, the company provides hands-on consulting and will provide seed funding to qualified incubator graduates and connections to next-stage funders. For more information visit http://www.murrietagenomics.com.

About EpigeneticsRX
EpigeneticsRx’s mission is to empower people to live an inspired, healthy life. The company identifies actionable genetic data and biomarkers to provide personalized health plans. EpigeneticsRX offers cost saving benefit programs to self-funded employers, government, health systems and payers. Services include customized, next generation sequencing (NGS) genomic panels and interpretation, online interactive learning, clinical research, controlled nutrigenomic formulary, proprietary epigenetic formulations and a network of trained practitioners. For more information visit http://www.epigeneticsrx.com.

Contact:
Jay Goth, Murrieta Genomics
951.704.6792
jgoth at murrietagenomics.com
Twitter: @jaygoth
Telegram: jaygoth
WeChat: jaygoth

Jay Goth, Murrieta Genomics, http://www.murrietagenomics.com, 9517046792, [email protected]

Modal title

Logo Murrieta Genomics
Logo Murrieta Genomics
Logo EpigeneticsRX
Logo EpigeneticsRX
Logo Murrieta Genomics Logo EpigeneticsRX

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.